Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKesson
Johnson and Johnson
Dow
Boehringer Ingelheim

Last Updated: June 28, 2022

Mutual Pharm Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MUTUAL PHARM, and what generic and branded alternatives to MUTUAL PHARM drugs are available?

MUTUAL PHARM has fifty-four approved drugs.



Summary for Mutual Pharm
US Patents:0
Tradenames:24
Ingredients:23
NDAs:54

Drugs and US Patents for Mutual Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm LORAZEPAM lorazepam TABLET;ORAL 070472-001 Dec 10, 1985 DISCN No No See Plans and Pricing See Plans and Pricing
Mutual Pharm DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062391-001 Sep 30, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
Mutual Pharm PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070115-001 Jun 12, 1985 DISCN No No See Plans and Pricing See Plans and Pricing
Mutual Pharm HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088728-001 Apr 11, 1985 DISCN No No See Plans and Pricing See Plans and Pricing
Mutual Pharm METRONIDAZOLE metronidazole TABLET;ORAL 018818-001 Feb 16, 1983 DISCN No No See Plans and Pricing See Plans and Pricing
Mutual Pharm CHLORTHALIDONE chlorthalidone TABLET;ORAL 087292-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Mallinckrodt
Harvard Business School
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.